Thomas is a dynamic life-science entrepreneur who established Santhera Pharmaceuticals (SIX Exchange: SANN) as successful Biotech/Specialty Pharma company in the Basel area (Switzerland). In the past 20 years he held executive manager positions (CSO and CEO) at Santhera and successfully executed merger/acquisitions, product licensing and turn-around situations.
He stepped down as Santhera’s CEO in late 2019 and became Managing Partner at Viopas Venture Consulting in 2020. Currently Thomas holds four Board positions.
Thomas has a PhD in Biology and is lecturer in neurosciences at the Biozentrum, University of Basel. He is an internationally recognized scientist with track record in clinical research of orphan diseases.